Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b StudyGuillermo Garcia‐Manero, Harinder Gill, Yasmin Abaza et al.|Blood|2024Cited by 9
Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndrome.Flavia Salvi, Alessandro Levis, Angelo Colaemma et al.|Blood|2009Cited by 0
Myelodysplastic Neoplasms Patients' and Caregivers' Unmet Needs and Their Impact on Their Quality of Life and SymptomsElena Crisà, Esther Natalie Olíva, Daniela Cilloni et al.|Blood|2024Cited by 0
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and CaregiversElena Crisà, Esther Natalie Olíva, Daniela Cilloni et al.|Preprints.org|2025Cited by 0